Trials / Unknown
UnknownNCT05049070
Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction
A Prospective, Multicenter, Open Label Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction Assessed by GoEyes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 349 (estimated)
- Sponsor
- 1800 Contacts, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the reliability, validity and safety of a self administered, subjective refraction test via a mobile medical app (GoEyes) as compared to standard of care subjective manifest refraction performed by a health care provider, in subjects who have no known ocular disease or condition other than refractive error.
Detailed description
GoEyes is a Mobile Medical Application, which can be downloaded to a smartphone and is being developed as a self -administered subjective refraction examination that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals. The Study will be conducted in 2 parts; Part 1 and Part 2. Approximately 59 participants will be enrolled In Part 1. Part 1 participants will have a GoEyes refraction test in clinic on two separate days and will also have a standard of care refraction test performed by a health care provider and best corrected visual acuity assessments. Approximately 349 participants will be enrolled in Part 2. Part 2 participants will self administer the GoEyes test at home on 2 separate days and will also have in clinic standard of care refraction test performed by a health care provider and best corrected visual acuity assessments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Mobile medical application to self administer a subjective refraction test | GoEyes is a software as a medical device and mobile medical application, which is downloaded to a smartphone and is a self-administered subjective refraction test that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals |
| DIAGNOSTIC_TEST | Standard of care refraction test | Standard of care subjective manifest refraction test performed by a healthcare professional |
Timeline
- Start date
- 2021-09-15
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2021-09-17
- Last updated
- 2023-04-06
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05049070. Inclusion in this directory is not an endorsement.